Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PFE crawled time : 13:00 save search
Bluerock Value Exchange Fully Subscribes $46.5 Million Diversified Industrial Portfolio I DST
Published: 2024-03-27 (Crawled : 13:00) - prnewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.43%
H: 0.81%
C: 0.25%
million
Dyadic Appoints Doug Pace to Its Executive Leadership Team
Published: 2023-10-09 (Crawled : 13:00) - globenewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.21%
H: 1.24%
C: 0.42%
NVS | News | $97.295 2.29% 0.0% 3.7M
|
Health Technology
|
| O: 0.01%
H: 0.47%
C: 0.45%
DYAI A | $1.5 -1.96% -2.0% 8.8K
|
Health Technology
|
| O: -2.45%
H: 0.0%
C: -2.01%
Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results
Published: 2023-08-09 (Crawled : 13:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.11%
H: 1.29%
C: 0.67%
INCY | $51.64 -0.54% 1.7M
|
Health Technology
|
| O: 0.08%
H: 2.08%
C: 1.3%
DCPH | $14.67 0.62% 0.61% 430K
|
Health Technology
|
| O: 4.95%
H: 2.5%
C: 1.18%
pharmaceuticals financial results
GlycoEra AG Expands Board of Directors and Appoints Santiago Arroyo, MD to its Board of Directors as an independent board member
Published: 2023-05-02 (Crawled : 13:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.2%
H: 2.1%
C: -0.59%
JNJ | News | $149.48 0.24% 6.8M
|
Health Technology
|
| O: 0.45%
H: 0.69%
C: 0.42%
Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-02-07 (Crawled : 13:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.14%
H: 0.18%
C: -0.52%
DCPH | $14.67 0.62% 0.61% 430K
|
Health Technology
|
| O: -1.02%
H: 3.75%
C: 0.24%
pharmaceuticals year financial results
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
Published: 2023-01-31 (Crawled : 13:00) - biospace.com/
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: -3.67%
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -1.26%
H: 2.97%
C: 2.7%
GSK | News | $41.245 1.61% 2M
|
Health Technology
|
| O: 0.85%
H: 0.31%
C: -0.45%
BHVN | News 0 d | $39.815 3.87% 1.7M
|
Health Technology
|
| O: -0.48%
H: 4.49%
C: 3.24%
BNTX | News | $88.51 0.57% 280K
|
Health Technology
|
| O: -1.74%
H: 4.84%
C: 3.88%
BEAM | $23.54 -2.32% 920K
|
Health Technology
|
| O: 0.21%
H: 4.84%
C: 2.99%
financial results
Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries
Published: 2023-01-17 (Crawled : 13:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -2.74%
H: 0.43%
C: -0.99%
offering
The Worldwide Lysosomal Disease Treatment Industry is Expected to Reach $11 Billion by 2028
Published: 2023-01-13 (Crawled : 13:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.13%
H: 0.76%
C: 0.76%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 2.77%
H: 0.63%
C: 0.63%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.13%
H: 2.35%
C: 2.16%
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.44%
H: 1.39%
C: 0.74%
NVS | News | $97.295 2.29% 0.0% 3.7M
|
Health Technology
|
| O: 0.15%
H: 0.65%
C: 0.4%
JNJ | News | $149.48 0.24% 6.8M
|
Health Technology
|
| O: -0.47%
H: 0.47%
C: 0.14%
LLY | News | $745.06 1.88% 0.0% 2M
|
Health Technology
|
| O: 0.13%
H: 1.04%
C: 0.57%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
BMRN | $92.06 2.87% 2.79% 1.3M
|
Health Technology
|
| O: -1.16%
H: 2.27%
C: 0.42%
AZN | News | $70.93 1.14% 4.5M
|
Health Technology
|
| O: 1.27%
H: 0.78%
C: 0.15%
treatment disease expected
Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis
Published: 2022-12-21 (Crawled : 13:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.56%
H: 1.08%
C: 0.11%
fda ema ulcerative colitis
Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction than Standard-of-Care Risk Model Myriad Genetics, Inc., a leader in genetic testing and preci...
Published: 2022-12-09 (Crawled : 13:00) - biospace.com/
SXT | $69.89 1.33% 0.0% 340K
|
Distribution Services
|
| O: -0.42%
H: 0.97%
C: -0.33%
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.06%
H: 2.11%
C: -0.06%
TRIB | $1.81 -3.87% 2.8K
|
Health Technology
|
| O: -1.56%
H: 1.58%
C: -1.75%
REPL | $6.41 -0.16% -0.16% 1.2M
|
Health Technology
|
| O: -0.25%
H: 5.25%
C: 4.17%
MYGN | $18.595 0.57% 0.56% 510K
|
Health Technology
|
| O: -0.67%
H: 1.39%
C: -2.69%
IMGN | News | $31.23 0.03% 49M
|
Health Technology
|
| O: -0.19%
H: 0.77%
C: -0.77%
GILD | $67.01 0.09% 3.5M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -1.45%
BNTX | News | $88.51 0.57% 280K
|
Health Technology
|
| O: -0.05%
H: 0.75%
C: -0.83%
APM | $5.6 -1.06% 26K
|
Health Technology
|
| O: -16.14%
H: 19.24%
C: 14.67%
risk breast genetic cancer study
IDEAYA Biosciences Appoints Darrin M. Beaupre, M.D., Ph.D., as Chief Medical Officer to Lead Clinical Development of Expanding Clinical Pipeline
Published: 2022-11-28 (Crawled : 13:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.06%
H: 1.14%
C: 0.79%
IDYA | News | $39.025 3.82% 3.68% 490K
|
Health Technology
|
| O: -0.63%
H: 2.23%
C: -5.38%
medical
The Worldwide Diabetic Retinopathy Industry is Expected to Reach $7.7 Billion by 2027 at a 11.3% CAGR
Published: 2022-11-22 (Crawled : 13:00) - prnewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.33%
H: 1.88%
C: 1.53%
NVS | News | $97.295 2.29% 0.0% 3.7M
|
Health Technology
|
| O: 0.77%
H: 0.41%
C: 0.27%
REGN | News | $906.84 0.74% 0.74% 340K
|
Health Technology
|
| O: 0.66%
H: 0.79%
C: 0.72%
ALIM | $3.59 1.41% 1.39% 16K
|
Health Technology
|
| O: 0.47%
H: 7.5%
C: -1.17%
expected diabetic
Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer
Published: 2022-11-08 (Crawled : 13:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.11%
H: 1.51%
C: 0.66%
ZLAB | $15.13 0.93% 0.93% 470K
|
Health Technology
|
| O: -2.4%
H: 0.0%
C: -4.57%
KSQ Therapeutics Announces Leadership and Board Additions
Published: 2022-09-23 (Crawled : 13:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.29%
H: 0.27%
C: -0.81%
therapeutics
Pfizer Declares Fourth-Quarter 2022 Dividend
Published: 2022-09-22 (Crawled : 13:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.57%
H: 3.05%
C: 2.06%
ViiV Healthcare presents positive five-year data at AIDS 2022, demonstrating the durability of fostemsavir in people living with HIV who are heavily treatment-experienced
Published: 2022-07-29 (Crawled : 13:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.32%
H: 0.3%
C: -0.1%
hiv positive living
EYENOVIA ANNOUNCES APPOINTMENT OF OPHTHALMIC INDUSTRY VETERAN MICHAEL ROWE AS CHIEF EXECUTIVE OFFICER AND BOARD MEMBER
Published: 2022-07-27 (Crawled : 13:00) - eyenoviabio.com
PPRUF | News | $364.27 37.56% 850
|
Consumer Non-Durables
|
| O: -3.74%
H: 6.93%
C: 1.74%
PPRUY | News | $36.96 -0.11% 220K
|
Manufacturing
|
| O: 1.31%
H: 1.65%
C: 0.55%
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.69%
H: 0.61%
C: 0.02%
EYEN | $0.537 3.97% 800K
|
Health Technology
|
| O: 0.0%
H: 2.37%
C: 1.18%
AERI | $15.25 0.0%
|
Health Technology
|
| O: 1.17%
H: 1.41%
C: -2.18%
Oligomerix Announces Key Organizational Changes in Transition to Clinically Focused Company
Published: 2022-07-20 (Crawled : 13:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.04%
H: 0.14%
C: -1.11%
Pfizer Provides Update on Ownership Interest in Haleon
Published: 2022-06-01 (Crawled : 13:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
MS | News 0 d | $93.79 1.85% 0.0% 6.4M
|
Finance
|
| O: 1.51%
H: 0.0%
C: 0.0%
GSK | News | $41.245 1.61% 2M
|
Health Technology
|
| O: -0.39%
H: 0.05%
C: -1.6%
FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John McGraw to Advisory Board
Published: 2022-04-21 (Crawled : 13:00) - biospace.com/
SYK | $334.91 2.21% -0.01% 1.4M
|
Health Technology
|
| O: 1.27%
H: 0.0%
C: 0.0%
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.16%
H: 0.0%
C: 0.0%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 1.59%
H: 0.0%
C: 0.0%
GILD | $67.01 0.09% 3.5M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
HUGE | News | $0.4732 -3.23% 100K
|
Process Industries
|
| O: 0.0%
H: 0.0%
C: 0.0%
pharma
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.99 139.2% 64M
|
Finance
EDBL | News | $6.47 72.07% 1.9M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
AEON | $4.235 -10.27% 66K
|
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 870K
|
HKIT | $1.345 31.86% 380K
|
Technology Services
OST | $0.512 28.0% 21.88% 290K
|
ABVC | $1.33 27.89% 6.9M
|
Wholesale Trade
Your saved searches
Save your searches and get alerts when important news are released.